As of May 10, 2025, ReShape Lifesciences's market capitalization has reached $3.00 M. According to our data, ReShape Lifesciences is the 44177th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
ReShape Lifesciences has seen its market value drop from $19.83 M to $3.00 M since 2020, representing a total decrease of 84.85% and an annual compound decline rate (CAGR) of 35.15%.
Date
Market Cap
Change (%)
May 10, 2025
$3.00 M
49%
December 31, 2024
$3.18 M
-31.26%
December 29, 2023
$4.62 M
41.89%
December 30, 2022
$3.26 M
-88.83%
December 31, 2021
$29.16 M
47.08%
December 31, 2020
$19.83 M
Company Profile
ReShape Lifesciences was founded in 2002 in United States.
The company went public on November 15, 2007
on the Nasdaq Stock Market.
With 18 employees, it focuses on Healthcare and aims to drive innovation in Medical Devices.
Frequently Asked Questions
As of May 10, 2025, ReShape Lifesciences (including the parent company, if applicable) has an estimated market capitalization of $3.00 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
ReShape Lifesciences global market capitalization ranking is approximately 44177 as of May 10, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.